CD8A and cancer: MAPK4 expression correlates negatively with infiltration by CD8+ T cells, plasmacytoid DC cells and T helper cells and correlates positively with the expression of inhibitory immune checkpoint proteins, which have been recognized as immunotherapy targets in cancer.25, 26